Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2018-12-11 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AJACCIO (20000), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ALBERT 1ER : revenue, balance sheet and financial ratios
PHARMACIE ALBERT 1ER is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AJACCIO (20000),
this company of category PME
shows in 2022 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ALBERT 1ER (SIREN 844555599)
Indicator
2023
2022
2021
2020
2019
Revenue
N/C
2 163 440 €
N/C
N/C
N/C
Net income
49 294 €
147 161 €
148 060 €
118 692 €
83 146 €
EBITDA
N/C
190 310 €
N/C
N/C
N/C
Net margin
N/C
6.8%
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE ALBERT 1ER generates positive net income of 49 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2023: 83 k€ -> 49 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
49 294 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 150%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
149.605%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.162%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE ALBERT 1ER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Debt ratio
1001.039
505.139
266.683
179.505
149.605
Financial autonomy
7.377
14.345
23.718
30.82
34.162
Repayment capacity
None
None
None
6.188
None
Cash flow / Revenue
None%
None%
None%
7.333%
None%
Sector positioning
Debt ratio
149.62023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.22
Average
In 2023, the debt ratio of PHARMACIE ALBERT 1ER (149.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
34.16%2023
2021
2022
2023
Q1: 28.71%
Med: 48.51%
Q3: 68.18%
Average+7 pts over 3 years
In 2023, the financial autonomy of PHARMACIE ALBERT 1ER (34.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.19 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE ALBERT 1ER (6.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 190.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
190.768
Liquidity indicators evolution PHARMACIE ALBERT 1ER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
Liquidity ratio
141.874
202.174
189.024
211.667
190.768
Interest coverage
None
None
None
5.354
None
Sector positioning
Liquidity ratio
190.772023
2021
2022
2023
Q1: 135.26
Med: 189.75
Q3: 270.27
Good
In 2023, the liquidity ratio of PHARMACIE ALBERT 1ER (190.77) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
5.35x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE ALBERT 1ER (5.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 119 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 893 days. Excellent situation: suppliers finance 774 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
119 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
893 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ALBERT 1ER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
255 870 €
0 €
Inventory turnover (days)
0
0
0
40
0
Customer payment term (days)
98
100
116
5
119
Supplier payment term (days)
1035
638
726
43
893
Positioning of PHARMACIE ALBERT 1ER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE ALBERT 1ER is estimated at
581 643 €
(range 353 725€ - 817 660€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
353k€581k€817k€
581 643 €Range: 353 725€ - 817 660€
NAF 5 année 2023
Valuation method used
Net Income Multiple
49 294 €
×
11.8x
=581 643 €
Range: 353 725€ - 817 660€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ALBERT 1ER with other companies in the same sector:
Frequently asked questions about PHARMACIE ALBERT 1ER
What is the revenue of PHARMACIE ALBERT 1ER ?
The revenue of PHARMACIE ALBERT 1ER in 2022 is 2.2 M€.
Is PHARMACIE ALBERT 1ER profitable?
Yes, PHARMACIE ALBERT 1ER generated a net profit of 49 k€ in 2023.
Where is the headquarters of PHARMACIE ALBERT 1ER ?
The headquarters of PHARMACIE ALBERT 1ER is located in AJACCIO (20000).
Where to find the tax return of PHARMACIE ALBERT 1ER ?
The tax return of PHARMACIE ALBERT 1ER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ALBERT 1ER operate?
PHARMACIE ALBERT 1ER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart